|
name click to compare prices |
» Shop local, ethical and at the best price on Ethishop |
|
|
|
Business & market
Subsidiaries
shareholder | country | % | source |
|
country | address & contact : production type incentive source |
South Africa | Allergan Pharmaceuticals (Proprietary) Limited : |
Bermuda | Allergan Holdings B, Ltd. : |
Brazil | Allergan Produtos Farmacêuticos Ltda : |
Chile | Allergan Laboratorios Limitada : |
Ireland | Allergan Pharmaceuticals Holdings (Ireland) Limited : |
Ireland | Allergan Services International, Limited : |
Mexico | Allergan, S.A. de C.V. : |
Turkey | Allergan Optik Mamulleri Sanayi Ve Ticaret Limited : |
|
year name | photo position; compensation source |
2003Ball, F Michael | Vice-president; salary: 0,73 million US$; stock-options: 0,48 million US$;
|
2003Kaplan, Lester | Vice-president; salary: 0,79 million US$; stock-options: 4,02 million US$;
|
2002Brandt, Eric | Chief Financial Officer; salary: 0,68 million US$;
|
2002Pyott, David | Chief Executive Officer; salary: 2,07 million US$;
|
|
year | employees <> | social impact : country source |
2005 | -76 | Internal restructuring: | Les Echos |
|
year | employees <> | social impact : country source |
|
year |   | sales | income | | | source |
2003 |
| 1,77 | -0,05 | |   | billion US$ | |
2002 |
| 1,43 | 0,08 | |   | billion US$ | |
2001 |
| 1,75 | 0,22 | |   | billion US$ | |
2000 |
| 1,63 | 0,22 | |   | billion US$ | |
1999 |
| 1,45 | 0,19 | |   | billion US$ | |
1998 |
| 1,3 | -0,09 | |   | billion US$ | |
|
year | financial misdemeanor | sales | income | assets | buyback | source |
|
year | purpose : intermediary/lobby : institution source |
2000 | Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate | Washington Post |
|
year | purpose : intermediary/lobby : institution source |
|
|
|